| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |